growthpatent

126 results found.

Top Stocks matching your search for "growth patent"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 22, 2023

$RSLS shows a strong growth in Revenue.

Feb, 17, 2023

Long term growth incoming!

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
FSR

Fisker Inc

-28.83%

$8.15 - $5.80

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

$FSR shows a strong growth in Revenue.

Mar, 20, 2023

$FSR shows a strong growth in Revenue.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Oct, 28, 2022

$SLRX SP-3164 showed significant tumor growth &q... See more

RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 22, 2023

$RSLS shows a strong growth in Revenue.

Feb, 17, 2023

Long term growth incoming!

Feb, 16, 2023

I feel the company is heading in a direction this time around for long term and sustainable growth.

Feb, 7, 2023

$RSLS is expected to show a strong growth in EPS.

Feb, 3, 2023

Huge watcher growth!

Feb, 3, 2023

Amazing watcher growth within a single day on Stocktwits!

FSR

Fisker Inc

-28.83%

$8.15 - $5.80

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

$FSR shows a strong growth in Revenue.

Mar, 20, 2023

$FSR shows a strong growth in Revenue.

Mar, 20, 2023

Looking at the last year, $FSR shows a very strong growth in Revenue.

Mar, 20, 2023

Looking at the last year, $FSR shows a very strong growth in Revenue.

Mar, 20, 2023

Our growth will be exponential.

Mar, 19, 2023

This stock offers the growth and energy efficiency going forward.

Mar, 19, 2023

Revenue is expected to show an annual growth rate (CAGR 2023-2027) of 17.02%, resulting in a projected market volume of US$858.00bn by 2027. 🔥🍺

Mar, 17, 2023

Banks collapse and strong growth and tech have pushed!!

Mar, 17, 2023

$FSR is expected to show a strong growth in EPS.

Mar, 16, 2023

Also remember, growth will only continue from here.

SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Oct, 28, 2022

$SLRX SP-3164 showed significant tumor growth "inhibition" in in vivo studies including statistically significant improvement over the approved immunomodulatory drugs lenalidomide (Revlimid®) and pomalidomide (Pomalyst®)